Glimepiride Tablets
Designed to support glycaemic control, utilized to address type 2 diabetes.
Strengths: 1 · 2 · 4mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Amaryl
- Therapeutic class
Sulfonylurea
- Pharmacological class
Sulfonylurea Antidiabetic
- Minor side effects
hypoglycaemia; dizziness; nausea
- Moderate side effects
weight gain; visual disturbance
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Designed to support glycaemic control, utilized to address type 2 diabetes.
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
2–3 hours
- Duration
24 hours
- Storage instructions
Store below 30°C.
- Drug interactions
alcohol; beta blockers; aspirin
- Age restrictions
Adults only
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to glimepiride; type 1 diabetes; diabetic ketoacidosis; severe renal impairment; severe hepatic impairment
Precautions and warnings
risk of hypoglycaemia; carry sugar source; regular blood glucose monitoring necessary; may impair ability to drive or operate machinery
Serious side effects
severe hypoglycaemia — requires immediate medical attention; haemolytic anaemia — requires immediate medical attention
Mechanism of action
Glimepiride is a long-acting sulfonylurea that stimulates insulin secretion from beta cells in the pancreas. It lowers blood glucose levels by increasing the insulin sensitivity of peripheral tissues.
Glimepiride Tablets
Designed to support glycaemic control, utilized to address type 2 diabetes.
Editorial Notes
- Active ingredient(s): Glimepiride
- Listed indication(s): Type 2 Diabetes Mellitus
Usually available as
- 180 tablets - 1 mg1391-1-mg-16677
- 90 tablets - 2 mg1391-2-mg-16682
- 90 tablets - 4 mg1391-4-mg-16690